In Silico Studies of Crystal Structure of HCV NS5B Polymerase and Inhibitor Complex

被引:0
|
作者
Tiwari, Gargi [1 ]
Pandey, Vishnudatt [1 ]
Tiwari, Rakesh Kumar [1 ]
Ojha, Rajendra Prasad [1 ]
机构
[1] DDU Gorakhpur Univ, Dept Phys, Biophys Unit, Gorakhpur, Uttar Pradesh, India
关键词
QM/MM Molecular Dynamics Simulations; HCV; Hydrogen Bonding; AB-INITIO CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; ZEOLITE CATALYSTS; SYSTEMS; ALUMINOSILICATES; STABILIZATION; FIELD; ION; RNA;
D O I
10.1016/j.matpr.2018.05.029
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Quantum mechanics/molecular mechanics (QM/MM) and molecular dynamics simulations were performed to study the hydrogen bonding and polar interactions of an inhibitor namely 2-{[(5-bromothiophen-2-yl) sulfonyl] amino}- 4-chlorobenzoic acid with HCV NS5B polymerase. Using the initial poses, our aim is to identify the minimum energy positions and calculate binding affinities of inhibitor to HCV. Results suggest that the accuracy of binding affinity prediction can be significantly affected by the proper treatment of the hydrogen bonding and polar interactions. Using this protocol, we successfully identified important poses of low RMSD with respect to crystallographic structure from the initially docked poses. This work shows that the most important energetic component contributing to binding for this particular protein-ligand system is the conformational energy. In addition, formation of hydrogen bonds can produce favorable van der Waals interactions with some important residues. This systematic study can provide guidance for the choice of QM/MM MD methods and design of new inhibitors targeting HCV. (c) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15431 / 15438
页数:8
相关论文
共 50 条
  • [21] CVVS-732: A Conformational Modulator of NS5B Polymerase Acting a Potent HCV Inhibitor
    Guedat, Philippe
    Valarche, Isabelle
    Lahmar, Mehdi
    Berecibar, Amaya
    Batard, Luc
    Bertrand, Angelina
    Martin, Aurelie
    Piessens, Annick
    Fernagut, Celine
    Freslon-Evain, Caroline
    Besnard, Lucie
    Ventura, Michel
    Durand, Tony
    Feray, Cyrille
    Mehtali, Majid
    GASTROENTEROLOGY, 2012, 142 (05) : S963 - S963
  • [22] Efficient and stereoselective synthesis of PSI-6130: Potent inhibitor of HCV NS5B polymerase
    Wang, Peiyuan
    Chun, Byoung-Kwon
    Rachakonda, Suguna
    Du, Jinfa
    Khan, Noshena
    Shi, Junxing
    Stec, Wojciech J.
    Cleary, Darryl
    Ross, Bruce S.
    Sofia, Michael J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [23] IDX21437, a novel nucleotide analogue prodrug HCV NS5B polymerase inhibitor
    Sullivan-Bolyai, J.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 31 - 32
  • [24] Discovery of ABT-072, a potent inhibitor of HCV NS5B polymerase in clinical trials
    Randolph, John T.
    Krueger, Allen C.
    Donner, Pamela L.
    Motter, Christopher E.
    Pratt, John K.
    Liu, Dachun
    Rockway, Todd W.
    Wagner, Rolf
    Hernandez, Lisa E.
    Beno, David W. A.
    Lim, Hock B.
    Beyer, Jill M.
    Mondal, Rubina
    Mistry, Neeta
    Colletti, Lynn
    Liu, Yaya
    Koev, Gennadiy
    Kati, Warren M.
    Longenecker, Kenton L.
    Stewart, Kent D.
    Molla, Akhteruzzaman
    Maring, Clarence J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [25] In vitro and in vivo ADME of a new hepatitis C virus (HCV) NS5B polymerase inhibitor
    Rioux, N
    Dong, KC
    Richard, A
    Roberge, G
    Bédard, J
    Chan, L
    Thumkunta, RJ
    Proulx, M
    Hamelin, BA
    DRUG METABOLISM REVIEWS, 2003, 35 : 39 - 39
  • [26] Robust suppression of viral replication in HCV infected chimpanzees by a nucleoside inhibitor of the NS5B polymerase
    Olsen, D. B.
    Carroll, S. S.
    Davies, M-El
    Handt, L.
    Koeplinger, K.
    Zhang, R.
    Ludmerer, S.
    MacCoss, M.
    Hazuda, D. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S7 - S7
  • [27] Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study
    Rehman, Sidra
    Ijaz, Bushra
    Fatima, Nighat
    Muhammad, Syed Aun
    Riazuddin, Sheikh
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 881 - 891
  • [28] In vitro studies of initiation of replication by the HCV RNA dependent RNA polymerase NS5B and the impact of NS5A
    Quezada, Elizabeth M.
    Kane, Caroline M.
    FASEB JOURNAL, 2007, 21 (05): : A282 - A282
  • [29] 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase
    McGowan, David
    Nyanguile, Origene
    Cummings, Maxwell D.
    Vendeville, Sandrine
    Vandyck, Koen
    Van den Broeck, Walter
    Boutton, Carlo W.
    De Bondt, Hendrik
    Quirynen, Ludo
    Amssoms, Katie
    Bonfanti, Jean-Francois
    Last, Stefaan
    Rombauts, Klara
    Tahri, Abdellah
    Hu, Lili
    Delouvroy, Frederic
    Vermeiren, Katrien
    Vandercruyssen, Genevieve
    Van der Helm, Liesbet
    Cleiren, Erna
    Mostmans, Wendy
    Lory, Pedro
    Pille, Geert
    Van Emelen, Kristof
    Fanning, Gregory
    Pauwels, Frederik
    Lin, Tse-I
    Simmen, Kenneth
    Raboisson, Pierre
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2492 - 2496
  • [30] Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors
    Nichols, Daniel B.
    Leao, Raquel A. C.
    Basu, Amartya
    Chudayeu, Maksim
    de Moraes, Paula de F.
    Talele, Tanaji T.
    Costa, Paulo R. R.
    Kaushik-Basu, Neerja
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (05) : 607 - 614